LimphoStat-B ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

53. シェーグレン症候群

---

臨床試験数 : 305 /  薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01008982 (ClinicalTrials.gov)	August 2009	5/11/2009	Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome	A Phase 2, Proof of Concept, 52-Week Open Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Primary Sjögren's Syndrome.	Sjögren's Syndrome	Drug: LimphoStat-B	University of Udine	Azienda Ospedaliera S. Maria della Misericordia	Completed	18 Years	90 Years	Both	15	Phase 2	Italy